PULMONX CORPORATION (LUNG) Free cash flow 2018–2025
PULMONX CORPORATION (LUNG) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$32.8MFY2025 · since FY2018: -$18.7M → -$32.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$32.8M | +0.5% |
| FY2024 | -$33.0M | +14.1% |
| FY2023 | -$38.4M | +17.2% |
| FY2022 | -$46.4M | -3.0% |
| FY2021 | -$45.1M | -42.8% |
| FY2020 | -$31.5M | -46.8% |
| FY2019 | -$21.5M | -14.8% |
| FY2018 | -$18.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LUNG financial trends
LUNG RevenueLUNG Net incomeLUNG Net marginLUNG Gross profitLUNG Gross marginLUNG Operating incomeLUNG Operating marginLUNG Operating cash flowLUNG Capital expendituresLUNG Return on equityLUNG Stock buybacksLUNG Dividends paidLUNG Total assetsLUNG Total liabilitiesLUNG Shareholders’ equityLUNG overview →